title: Y2 receptor-selective agonist delays the estrogen-induced luteinizing hormone surge in ovariectomized ewes, but y1-receptor-selective agonist stimulates voluntary food intake.
abstract: Neuropeptide Y (NPY) plays a major role in the regulation of food intake, regulation of homeostasis, and neuroendocrine function. We have previously shown that third ventricular infusion of this peptide delays the estradiol benzoate-induced surge in LH secretion in ovariectomized ewes. To determine the receptor subtype that transmits this effect, we have now used the same model to infuse a Y1 receptor agonist [NPY Leu31 Pro34], a Y2 receptor agonist (PYY3-36), and a Y4 receptor agonist (pancreatic polypeptide). We monitored the surges in animals given these agonists or artificial cerebrospinal fluid by measuring plasma LH levels, and we also measured daily voluntary food intake (VFI). A low (7 microg/h) dose of Y2 agonist delayed the surge but did not affect VFI, whereas a higher dose (14 microg/h) stimulated VFI. A dose of 18 microg/h of the Y1 agonist did not affect surge generation but also stimulated VFI. A dose of 24 microg/h of Y4 agonist affected neither surge generation nor VFI. These specificities are different from those reported for the rat and human (in which a Y2 agonist causes reduction in VFI). We conclude that, in sheep, the negative regulation of the reproductive axis by NPY and Y-receptor agonists is effected via the Y2 receptors, whereas the orexigenic effects are most likely effected via the Y1 receptors.
authors.affiliation: Prince Henry's Institute of Medical Research, P.O. Box 5152, Clayton, Victoria 3168, Australia. iain.clarke@phimr.monash.edu.au
authors.forename: Iain J
authors.initials: IJ
authors.lastname: Clarke
authors.forename: Kathryn
authors.initials: K
authors.lastname: Backholer
authors.forename: Alan J
authors.initials: AJ
authors.lastname: Tilbrook
mesh_terms: D000818:Animals; D004347:Drug Interactions; D004435:Eating / Q000187:drug effects / Q000502:physiology*; D004967:Estrogens / Q000494:pharmacology; D005260:Female; D007986:Luteinizing Hormone / Q000378:metabolism*; D009478:Neuropeptide Y / Q000031:analogs & derivatives* / Q000494:pharmacology; D010052:Ovariectomy; D010191:Pancreatic Polypeptide / Q000494:pharmacology; D010446:Peptide Fragments; D019894:Peptide YY / Q000494:pharmacology; D017476:Receptors, Neuropeptide Y / Q000819:agonists / Q000378:metabolism*; D012756:Sheep
chemical_list: D004967:Estrogens; D009478:Neuropeptide Y; D010446:Peptide Fragments; D017476:Receptors, Neuropeptide Y; C097212:neuropeptide Y-Y1 receptor; C095889:neuropeptide Y2 receptor; D019894:Peptide YY; C061785:peptide YY (3-36); C062259:neuropeptide Y, Leu(31)-Pro(34)-; C109491:neuropeptide Y4 receptor; D010191:Pancreatic Polypeptide; D007986:Luteinizing Hormone